Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Epizyme Inc (NQ: EPZM )

11.72 USD -0.24 (-1.96%)
Official Closing Price Updated: 4:01 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Epizyme Inc

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
27 28 Next >
Benzinga's Top #PreMarket Losers
Caladrius Biosciences Inc (NASDAQ: CLBS) shares fell 32.08 percent to $0.72 in pre-market trading after the company reported that it ... 
Tags PreMarket Losers KBH ATML
From Benzinga
Epizyme Prices ~13.33M Share Offering @$9.00/Share
Epizyme, Inc. (NASDAQ: EPZM) announced Wednesday, the pricing of its public offering of 13,333,334 shares of its ... 
Tags News Offerings Benzinga
From Benzinga
Epizyme Announces Pricing of Public Offering of Common Stock
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, today announced the pricing of its public offering of 13,333,334... 
From Business Wire News Releases
MORNING CALL - January 6, 2016
Apple fell nearly 3% in pe-market trading after the Nikkei Asian Review reported that Apple would reduce Q1 output of its latest iPhones by about 30%. 
Tags Technology Stocks / Equities Healthcare
From Blogs - TalkMarkets
Epizyme to offer stock
Epizyme Inc. (Nasdaq: EPZM) will offer $120 million in common stock through a public offering. The stock price plunged $3.58 to close at $11.54.... 
From MarketMinute.com Stock News
Mid-Afternoon Market Update: Dow Slides Over 300 Points; Otonomy Shares Tumble Following Public Offering Of Stock
Toward the end of trading Wednesday, the Dow traded down 1.81 percent to 16,847.61 while the NASDAQ slipped 1.65 percent to 4,810.93. ... 
Tags Earnings Guidance News
From Benzinga
Markets extend losses as services sector expansion slows
Tags MXL EARS SWN
From MarketMinute » Market Updates
Markets extend losses as services sector expansion slows
The markets continued tumbling during the midday with the Dow plummeting 224 points to 16,934 as expansion of the nation's services sector slowed in December. Nasdaq plunged 43 points to 4,847. 
Tags Market News
From MarketMinute.com Market Updates
Mid-Day Market Update: Crude Oil Falls Over 4%; Conatus Pharmaceuticals Shares Rise Following Positive Results In Phase 2 Study
Midway through trading Wednesday, the Dow traded down 1.09 percent to 16,971.40 while the NASDAQ slipped 0.64 percent to 4,860.35. The ... 
Tags Mid/Day Market Update MXL SM
From Benzinga
Mid-Morning Market Update: Markets Open Lower; Monsanto Posts Narrower-Than-Expected Loss
Following the market opening Wednesday, the Dow traded down 1.37 percent to 16,923.22 while the NASDAQ slipped 1.25 percent to ... 
Tags EPZM Mid/Morning Market Update Earnings
From Benzinga
Hottest Manufacturing Stocks Now – EARS TASR NPO BCRX
 
Tags NASDAQ:GBT NASDAQ:CBIO NASDAQ:CEMP
From InvestorPlace
Epizyme Announces Proposed Public Offering of Common Stock
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, today announced that it intends to offer and sell up to $120,000,000... 
From Business Wire News Releases
Biggest Movers in Manufacturing Stocks Now – CPSH NL INNL AGRX
 
Tags NASDAQ:GBIM NASDAQ:STML NASDAQ:EPZM
From InvestorPlace
Epizyme Announces First Patient Dosed in Global Clinical Program Evaluating Tazemetostat in Genetically Defined Solid Tumors
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, announced today that the first patient has been dosed in the phase 2... 
From Business Wire News Releases
10 Biotechs Short Sellers Are Betting Against
In a report issued Monday, Jefferies analysts Eun K. Yang and Carmen Augustine looked into short interest in the biotech ... 
Tags Short Ideas Trading Ideas Eun K/ Yang
From Benzinga
Short Interest Jumps 11.4% For EPZM
The most recent short interest data has been released by the NASDAQ for the 12/15/2015 settlement date, which shows a 619,146 share increase in total short interest for Epizyme Inc. (EPZM), to... 
Tags Stocks
From Market News Video
Where We Are Headed - Analyst Research on ArcelorMittal, Epizyme, NII Holdings and DRDGOLD
Tags Business & Professional Services
From ACCESSWIRE
Epizyme Announces FDA Acceptance of Investigational New Drug Application for Tazemetostat in Diffuse Large B-cell Lymphoma
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, today announced the U.S. Food and Drug Administration’s (FDA) Division... 
From Business Wire News Releases
Biggest Movers in Manufacturing Stocks Now – ADXS ARRY CBYL OVAS
 
Tags NASDAQ:OVAS NASDAQ:SHLO NYSE:AGCO
From InvestorPlace
Epizyme Presents Updated Data from Ongoing Phase 1 Study of Tazemetostat Showing Objective, Durable Responses in Relapsed or Refractory Non-Hodgkin Lymphoma
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, reported updated results from the ongoing phase 1 trial of... 
From Business Wire News Releases
13 Biotechnology Stocks to Sell Now
 
Tags NASDAQ:SGMO NASDAQ:AMAG NASDAQ:IRWD
From InvestorPlace
Epizyme, Inc. to Present at Piper Jaffray Conference on December 1, 2015
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, will participate in the Piper Jaffray 27th Annual Healthcare... 
From Business Wire News Releases
Biggest Movers in Manufacturing Stocks Now – HDNG PTCT BLUE VNRX
 
Tags NASDAQ:FGEN NASDAQ:HAYN NASDAQ:PATK
From InvestorPlace
Epizyme Announces Third Quarter 2015 Financial Results and Provides Corporate Update
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, today reported business highlights and operating and financial results... 
From Business Wire News Releases
Epizyme Announces Presentations at 57th American Society of Hematology Annual Meeting
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, announced today that data from the ongoing phase 1 study of tazemetostat... 
From Business Wire News Releases
Epizyme to Present New Scientific Data on the Role of HMT Inhibitors in Cancer
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, will present data from 11 accepted abstracts on the role of histone... 
From Business Wire News Releases
Hottest Manufacturing Stocks Now – EFOI SGI JASN IMN
 
Tags NASDAQ:ALDR NASDAQ:SCMP Hot Stocks
From InvestorPlace
Biggest Movers in Manufacturing Stocks Now – CYTK BLCM CLLS IMN
 
Tags NASDAQ:EPZM NYSE:TMST NYSE:IMN
From InvestorPlace
Epizyme to Report Third Quarter 2015 Financial Results and Provide Corporate Update on November 9, 2015
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, announced today it will host a conference call and live audio... 
From Business Wire News Releases
Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now
Leerink recently hosted 24 biopharmaceutical companies at a roundtable event. Of the 24 companies, Leerink now rates 20 of them as ... 
Tags Analyst Ratings Analyst Color SAGE
From Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account